Skip to main content
Consun Pharmaceutical Group Limited logo

Consun Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1681 HKEX Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2025-12-08 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 1681

About Consun Pharmaceutical Group Limited

http://www.chinaconsun.com

Consun Pharmaceutical Group Limited is a modern pharmaceutical enterprise engaged in the integrated research, development, manufacturing, and marketing of pharmaceutical products. The company's core business is segmented into Modern Chinese Medicines (MCM) and Medical Contrast Medium products. The MCM portfolio targets major therapeutic areas, including chronic renal diseases (featuring products like Uremic Clearance Granules), liver and gallbladder conditions, and orthopedic trauma. In the medical imaging field, Consun supplies contrast agents such as Gadopentetate Dimeglumine Injection for magnetic resonance imaging (MRI) and Iopamidol Injection for angiography and neuro-radiology. The enterprise focuses on combining the modernization of Chinese medicine with advanced diagnostic solutions.

Recent filings

Filing Released Lang Actions
Notification Letter to Registered Shareholders and Reply Form
Report Publication Announcement Classification · 1% confidence The document is a 'Notification Letter' from Consun Pharmaceutical Group Limited to its shareholders regarding the electronic dissemination of corporate communications. It informs shareholders that documents such as annual reports, circulars, and proxy forms are now available on the company's website and provides a 'Reply Form' for shareholders to choose their preferred communication method (electronic vs. printed). This is a standard administrative notice regarding the publication and distribution of corporate materials, which falls under the category of a Report Publication Announcement (RPA).
2025-12-08 English
Notification Letter to Non-Registered Shareholders and Reply Form
Report Publication Announcement Classification · 1% confidence The document is a 'Notification Letter' from Consun Pharmaceutical Group Limited informing non-registered shareholders about the publication of a circular and notice of an Extraordinary General Meeting. It provides instructions on how to access these documents electronically or request printed copies. It is a standard administrative communication regarding the dissemination of corporate materials, which falls under the category of a Report Publication Announcement (RPA).
2025-12-08 English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Form of Proxy' for an Extraordinary General Meeting (EGM). It provides shareholders with the ability to appoint a proxy to vote on specific resolutions (share award scheme, service provider sublimit, and amendments to articles of association). This document is a standard material sent to shareholders to solicit their votes and provide information regarding the meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-12-08 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Extraordinary General Meeting' (EGM) issued by Consun Pharmaceutical Group Limited. It outlines the agenda for an upcoming meeting, including ordinary and special resolutions regarding a share award scheme and amendments to the articles of association. It also provides instructions for shareholders on how to vote, appoint proxies, and attend the meeting. This document is a solicitation of shareholder action and information for an upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-12-08 English
(1) PROPOSED ADOPTION OF THE SHARE AWARD SCHEME, (2) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND (3) N
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a circular issued by Consun Pharmaceutical Group Limited to its shareholders. It contains detailed information regarding proposed corporate actions (adoption of a share award scheme and amendments to the articles of association) and includes a formal 'Notice of EGM' (Extraordinary General Meeting). Such documents are distributed to shareholders to provide necessary information and request their votes on specific resolutions, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2025-12-08 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It details specific share repurchase transactions conducted by Consun Pharmaceutical Group Limited on 05 December 2025, including the number of shares, price, and aggregate cost. This document type is specifically used for reporting share buybacks and changes in issued shares, which falls under the 'Transaction in Own Shares' category.
2025-12-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.